Data / Drug companies / Trazodone hydrochloride
Trazodone hydrochloride: 39 companies and 165 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Trazodone hydrochloride is listed in the FDA National Drug Code Directory by 39 companies, with 165 products in commercial distribution. 165 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, film coated, and the newest product started marketing on October 16, 2026.
The request: Get every company that lists trazodone hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 39
- Products
- 165
- Generic (ANDA) products
- 165 (100.0%)
- Application numbers
- 14
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list trazodone hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 15 | tablet | Generic drugs (ANDA) | October 17, 2018 |
| Remedyrepack Inc. | 14 | tablet; tablet, film coated | Generic drugs (ANDA) | September 22, 2026 |
| A-S Medication Solutions | 10 | tablet | Generic drugs (ANDA) | January 22, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | 8 | tablet | Generic drugs (ANDA) | November 6, 2020 |
| PD-Rx Pharmaceuticals, Inc. | 6 | tablet | Generic drugs (ANDA) | October 8, 2020 |
| Proficient Rx LP | 6 | tablet | Generic drugs (ANDA) | October 8, 2020 |
| Zydus Lifesciences Limited | 6 | tablet | Generic drugs (ANDA) | January 22, 2026 |
| Zydus Pharmaceuticals USA Inc. | 6 | tablet | Generic drugs (ANDA) | January 22, 2026 |
| Advanced Rx of Tennessee, LLC | 5 | tablet | Generic drugs (ANDA) | March 20, 2025 |
| American Health Packaging | 5 | tablet | Generic drugs (ANDA) | October 11, 2026 |
| Major Pharmaceuticals | 5 | tablet | Generic drugs (ANDA) | October 16, 2026 |
| NuCare Pharmaceuticals,Inc. | 5 | tablet | Generic drugs (ANDA) | December 11, 2017 |
| Accord Healthcare Inc. | 4 | tablet | Generic drugs (ANDA) | October 25, 2018 |
| Apotex Corp. | 4 | tablet | Generic drugs (ANDA) | January 5, 2009 |
| Asclemed USA, Inc. | 4 | tablet | Generic drugs (ANDA) | December 11, 2017 |
| Aurolife Pharma, LLC | 4 | tablet | Generic drugs (ANDA) | September 15, 2015 |
| Coupler LLC | 4 | tablet, film coated; tablet | Generic drugs (ANDA) | July 6, 2026 |
| Granules Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | August 9, 2024 |
| Rising Pharma Holdings, Inc. | 4 | tablet | Generic drugs (ANDA) | January 29, 2025 |
| Torrent Pharmaceuticals Limited | 4 | tablet | Generic drugs (ANDA) | November 27, 2013 |
| Asclemed USA Inc. | 3 | tablet | Generic drugs (ANDA) | November 27, 2013 |
| AvKARE | 3 | tablet | Generic drugs (ANDA) | November 6, 2020 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | September 15, 2015 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 3 | tablet | Generic drugs (ANDA) | October 8, 2020 |
| Preferred Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | June 5, 2018 |
| Sun Pharmaceutical Industries, Inc. | 3 | tablet, film coated; tablet | Generic drugs (ANDA) | October 3, 2022 |
| Teva Pharmaceuticals USA, Inc. | 3 | tablet | Generic drugs (ANDA) | October 8, 2020 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet | Generic drugs (ANDA) | August 8, 2024 |
| Cardinal Health 107, LLC | 2 | tablet | Generic drugs (ANDA) | December 11, 2017 |
| Golden State Medical Supply, Inc. | 2 | tablet | Generic drugs (ANDA) | August 8, 2024 |
| Medsource Pharmaceuticals | 2 | tablet | Generic drugs (ANDA) | December 11, 2017 |
| Northwind Health Company, LLC | 2 | tablet | Generic drugs (ANDA) | November 30, 2022 |
| Oxford Pharmaceuticals, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | March 1, 2023 |
| St. Mary's Medical Park Pharmacy | 2 | tablet | Generic drugs (ANDA) | October 14, 2026 |
| TruPharma, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | September 3, 2026 |
| Unit Dose Solutions, Inc. | 2 | tablet | Generic drugs (ANDA) | July 9, 2026 |
| AvPAK | 1 | tablet | Generic drugs (ANDA) | February 21, 2020 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | September 22, 2026 |
| Teva Pharmaceuticals USA, Inc. | 1 | tablet | Generic drugs (ANDA) | December 9, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 156 | 94.5% |
| Tablet, film coated | 9 | 5.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 165 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Serotonin Reuptake Inhibitor | 165 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.